SuperworthRegeneron Pharmaceuticals shares outstanding REGN
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 106M
- On a year earlier
- −2.4%
- fewer shares
Regeneron Pharmaceuticals had 106M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 107.7M | −5% |
| FY2024 | 113.6M | −0% |
| FY2023 | 113.7M | −0% |
| FY2022 | 114.1M | +1% |
| FY2021 | 113.4M | +1% |
| FY2020 | 112.1M | −2% |
| FY2019 | 114.3M | −0% |
| FY2018 | 114.7M | −1% |
| FY2017 | 115.6M | −0% |
| FY2016 | 115.8M | +0% |
| FY2015 | 115.5M | +1% |
| FY2014 | 114M | +16% |
| FY2013 | 98.6M | −25% |
| FY2012 | 132.1M | +44% |
| FY2011 | 91.8M | +5% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 106M | −2% | |
| Q1 FY26 | 107.7M | −3% | |
| Q4 FY25 | 107.7M | −5% | |
| Q3 FY25 | 107.2M | −8% | |
| Q2 FY25 | 108.6M | −6% | |
| Q1 FY25 | 111.2M | −3% | |
| Q4 FY24 | 113.6M | −0% | |
| Q3 FY24 | 116.2M | +2% | |
| Q2 FY24 | 115.4M | +1% | |
| Q1 FY24 | 115.1M | +1% | |
| Q4 FY23 | 113.7M | −0% | |
| Q3 FY23 | 113.4M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Regeneron Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.